Castle Biosciences (CSTL) Q1 2023 Earnings

3MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-1.1
-0.75
-0.41
-0.06

Details

Expected EPS
-0.89
Actual EPS
-1.1
Surprise EPS
-0.21
Surprise Percent
+23.6%

Description

Castle Biosciences (CSTL) has reported earnings of -1.1 per share for Q1 2023.

0 Comments

Share your thoughts